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Paper attitudes and practice in relation to first-episode
psychosis: a survey of child and adult psychiatrists
AIMS AND METHOD
Early intervention in psychosis
services serving the 14-35 age range
often receive input from psychiatrists
from both child and adolescent as
well as adult mental health services.
Differences in staff attitudes or
practices could potentially affect the
experience of care that an individual
with first-episode psychosis receives,
on the basis of their age. In order to
investigate such potential variation
a questionnaire-based survey was
conducted targeting the relevant
psychiatrists working in a large
mental health trust in North-East
England.
RESULTS
Only subtle differences in attitudes
between the two staff groups were
noted. However, a number of signifi-
cant differences in prescribing
preferences were reported.
CLINICAL IMPLICATIONS
Attitudes towards first-episode
psychosis show marked variation
between psychiatrists but may not
be especially associated with sub-
speciality. Further national guidance
should be drawn up, disseminated
and implemented to help ensure that
service users across the age range
receive the safest and most effective
medications for an episode of
psychotic illness, regardless of age.
Since the turn of the millennium there has been a drive to
design and implement early intervention services to
improve the experience of care encountered by indivi-
duals, aged 14-35, who develop psychotic illness. The
Department of Health Policy Implementation Guide
recommended that each early intervention service should
receive dedicated input from at least 0.1 whole time
equivalent Child and Adolescent Mental Health Service
(CAMHS) professional.1 In reality both coverage of the
adolescent client group and input from CAMHS has been
highly variable as early intervention has been imple-
mented; a 2005 survey of early intervention teams in
England reported that only one in six had any dedicated
input from a CAMHS professional.2 However, a survey
utilising subsequent data reported that only 26% of
services failed to provide input to the lower age range of
14- to 18-year-olds.3 In addition there are also examples
of early intervention models where a high degree of
integration between CAMHS and Adult Mental Health
Services (AMHS) has been achieved.4 Thus, it is likely that
most early intervention teams rely on some input from
child and adolescent psychiatrists when assessing and
managing younger service users affected by first-episode
psychosis.
Historically, managing the psychosis-spectrum of
illnesses has been viewed as the core business of many
adult psychiatrists whereas CAMHS predominantly
maintain a focus on the assessment and management of
developmental problems such as hyperkinesis and the
autism-spectrum disorders. Consequently many
psychiatrists working in CAMHS encounter psychosis
relatively infrequently in their practice, and may lack
recent experience and expertise in recognising or
managing severe mental illness presenting during
adolescence. Moreover, at the time of writing the
National Institute for Health and Clincial Excellence has
confined any specific recommendations in relation to
‘schizophrenia’ to adults5 although some guidance on the
assessment and treatment of bipolar affective disorder in
under 18s has been published.6
The factors outlined above could lead to differences
in the attitudes or practice of CAMHS v. adult psychia-
trists dealing with first-episode psychosis. This could
create differences in the experience of young people with
emerging severe mental illness, depending on whether
they are over 18 or not and thus is a potential source of
healthcare inequity. Hence, the aims of this study were to
explore whether psychiatrists working in CAMHS
reported significantly different attitudes or practices in
relation to first-episode psychosis when compared with a
sample of adult psychiatrists working in the same
organisation. The findings were intended to contribute to
early intervention service development and identify any
potential training needs for psychiatric staff.
Methods
A self-report postal questionnaire was composed in order
to gather information from psychiatrists regarding their
professional characteristics, practices and attitudes in
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relation to first-episode psychosis. A separate group of
ten psychiatrists were consulted on the draft version
before the final version was distributed. The questionnaire
collected information on three broad areas:
(a) professional characteristics (post, years in practice,
number of individuals with first-episode psychosis
seen);
(b) views andattitudes toward individuals affectedby first-
episode psychosis (categorisation, treatability, comor-
bidity, utility of prognostic factors etc);
(c) Practice (psychosocial andmedical interventions used
and views on relative effectiveness etc).
A variety of response formats were utilised, including
four-point Likert scales, matrices and ranked choices.
Statistical analysis was conducted using chi-squared tests
to compare responses between groups.
Tees, Esk and Wear Valleys is a NHS trust in an orga-
nisation that provides mental health services to a popu-
lation of 1.4 million living in Teesside, County Durham and
part of North Yorkshire in northern England. The ques-
tionnaire was posted to all psychiatrists working in either
the adult or child and family directorates during October
2007. Three months later a follow-up letter and copy of
the questionnaire was sent in order to maximise response
rates. In total the questionnaire was sent to 26 CAMHS
psychiatrists and 71 adult psychiatrists. Doctors working
in forensic, learning disability or older people’s services
were not included. Psychiatrists who were undergoing
basic specialist training (equivalent to senior house officer
or below) were also excluded from the study as some
may have had held posts in CAMHS but have lacked
experience of working with young people with first-
episode psychosis. Approval to conduct the staff survey
as part of service evaluation and development was
granted by the Tees, Esk and Wear Valleys Trust research
and development department and considered exempt
from external ethical review.
Results
Seventeen (65% completion rate) CAMHS psychiatrists
(all consultant level except for one staff grade psychia-
trist) returned a completed questionnaire as did 47
psychiatrists working in adult services (41 consultants, 2
specialist registrars and 4 staff grades) (66% completion
rate). There was no significant inter-group difference
between the groups in terms of years spent in practice
(mean 15.7 years for AMHS v. 16.5 for CAMHS). Most of
those working in AMHS reported seeing between 5 and
20 individuals with first-episode psychosis over the last 2
years. This figure was usually cited as between two and
five for the CAMHS psychiatrists, although five reported
seeing ten or more such individuals.
Attitudes to first-episode psychosis
Table 1 depicts the responses to the questions relating to
attitudes towards first-episode psychosis.When analysed
as dichotomised positive or negative responses to the
stems there were no statistically significant inter-group
differences. However, in the case of three items there
were significant inter-group trends observed when the
original four-point Likert responses were utilised: for
item 3 (confidence in dealing with first-episode
psychosis) 19 (of 47) adult psychiatrists reported feeling
‘very confident’ whereas only 1 (of 17) of the CAMHS
group indicated this level of confidence (w2= 9.7,
P= 0.02). Similarly, although most adult psychiatrists
(32/47) indicated they were ‘very likely’ to refer to early
intervention psychosis services only 6 (of 17) of the
CAMHS group made this response to item 8 (w2= 7.6,
P= 0.02). Lastly, CAMHS psychiatrists took a mildly more
pessimistic view of prognosis in first-episode psychosis;
only 1 (of 15) reported the view that outcome from first-
episode psychosis was ‘usually good’ for item 12. This
contrasted with the adult psychiatrists where 15 (of 47)
reported this view of outcome (w2= 9.5, P= 0.02).
Perceptions of prognostic factors
The groups were remarkably similar in their ratings of the
relative importance of the list of potential prognostic
factors listed (premorbid functioning, substance misuse,
family functioning, other social support, concordance
with medication, engagement with services, gender,
personality factors, persistent positive symptoms and
persistent negative symptoms). The factors felt to be
most predictive were substance misuse and concordance
with medication with around two-thirds of both groups
placing these in their top three prognostic factors. Only
about one-third of respondents viewed persistent nega-
tive symptoms or family functioning as relatively impor-
tant. Only ten psychiatrists placed gender or personality
factors in their top three.
Perceived comorbidities
Participants were invited to record their perceptions of
the five most common comorbidities in first-episode
psychosis, using a matrix (only those rated as in the top
three were analysed). On one side was a list of conditions
(specific developmental disorders; autism-spectrum
disorder; learning disability; emerging/borderline
personality disorder; antisocial personality disorder;
social phobia; other anxiety disorders; repeated self-
harm; obsessive-compulsive disorder; post-traumatic
stress disorder (PTSD); depression and; epilepsy).
Respondents recorded the frequency that they felt the
conditions co-occurred with first-episode psychosis.
Child and adult psychiatrists rated the frequency of
different categories of comorbid conditions in a similar
way with only three exceptions; child psychiatrists felt
that specific developmental disorders (w2= 5.1, P= 0.02)
and obsessive-compulsive disorder (w2= 9.2, P= 0.002)
more frequently co-existed with first-episode psychosis
compared with the adult psychiatrists. Conversely, adult
psychiatrists perceived more comorbid substance misuse
compared with the child psychiatrists (w2= 4.5, P50.03).
Treatment strategies
Antipsychotic prescribing habits
Respondents were presented with a selection of anti-
psychotics (risperidone, olanzapine, quetiapine,
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aripiprazole, amisulpride and other (to be specified) and
asked which would be their most common choice for a
first-line medication to use in ‘non-affective’ first-episode
psychosis. This exercise was repeated for ‘second most
common choice for first-line medication’, ‘most common
choice as a second-line medication’ and ‘second most
common choice as a second-line medication’. The results
are shown in Table 2. Child psychiatrists were significantly
more likely to express a preference for risperidone as a
first-line agent (w2= 22.3, P50.001). Conversely adult
psychiatrists more frequently cited risperidone as their
second commonest choice as a first-line agent (w2= 6.9,
P= 0.008) and were more likely to report olanzapine as
either a favourite first- or second-line treatment
compared with child psychiatrists (w2= 6.9, P= 0.008).
Respondents were asked how long they would wait
before changing the first-line antipsychotic drug if it
appeared ineffective at the maximum (British National
Formulary7 or tolerated dose) and presented with a
selection of 2-week time bands ranging from ‘52 weeks’
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Table 1. The responses of psychiatrists working in Adult Mental Health Services (AMHS) and Child and Adolescent Mental Health Services (CAMHS)
to the attitudinal questions
Response, n
Question n Yes No
1. Is distinguishing between ‘schizophreniform’ and ‘affective psychosis’ useful?
AMHS 47 37 10
CAMHS 17 13 4
2. Is specific diagnosis (e.g. bipolar affective disorder) useful after 1 month in first-episode
psychosis?
AMHS 47 34 13
CAMHS 17 11 6
3. Do you feel confident managing first-episode psychosis?a
AMHS 47 43 4
CAMHS 17 15 2
4. Is it rewarding working with individuals affected by first-episode psychosis?
AMHS 46 42 4
CAMHS 16 12 4
5. Is first-episode psychosis markedly different in adolescents compared to adults?
AMHS 46 26 20
CAMHS 17 11 6
6. Is ‘drug induced psychosis’ a valid diagnosis?
AMHS 46 36 10
CAMHS 17 13 4
7. Early intervention in psychosis services viewed positively
AMHS 47 41 6
CAMHS 17 16 1
8. Likely to refer to early intervention in psychosis team?a
AMHS 47 45 2
CAMHS 17 17 0
9. Medication is effective in treating first-episode psychosis
AMHS 47 47 0
CAMHS 16 16 0
10. Side-effects are common with antipsychotic medications
AMHS 45 39 6
CAMHS 17 15 2
11. Side-effects, when they occur are very or extremely problematic
AMHS 46 22 24
CAMHS 17 8 9
12. Prognosis in first-episode psychosis is generally or often poora
AMHS 47 6 41
CAMHS 15 4 11
13. Clozapine is significantly more effective than other antipsychotic medications
AMHS 47 40 7
CAMHS 14 12 2
14. Patients with first-episode psychosis are significantly more risky (to self and others)
compared to non-psychotic patients
AMHS 46 27 19
CAMHS 16 8 8
a. Items showed statistically significant different inter-group distributions of responses when analysed according to the original four-point Likert scoring (P = 0.02 in all
cases; see text).
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to ‘410 weeks’. The distribution of responses was
remarkably similar between the two groups with the
median response for both groups being ‘4-6 weeks’.
When presented with a selection of indications for a trial
of clozapine, almost all respondents selected ‘failure to
respond to adequate trial of two antipsychotics’.
Treatment of affective symptoms
Participants were asked what their first line approaches
to depressive symptoms (of more than 2 weeks duration)
in the context of a psychotic illness would likely be.
Respondents could select more than one (if desired) of
the following options: watchful waiting; Cognitive-
behavioural therapy (CBT); antidepressants; mood stabi-
liser; supportive psychotherapy; other (to be specified).
Most psychiatrists included watchful waiting (30/47 for
AMHS; 10/15 for CAMHS) and a similar proportion in
each group selected the other approaches. However,
CAMHS psychiatrists were significantly less likely to
consider prescribing an antidepressant in this context
when compared with their adult colleagues (1/15 v. 26/
47; w2= 10.9, P= 0.001). This difference in reported prac-
tice disappeared when the prompt changed to ‘more
persistent depressive symptoms lasting more than two
months’. In this latter case the majority of both groups
reported considering antidepressant treatment (36/46
for AMHS; 11/15 CAMHS).
The two groups also differed in some respects in
their reports of treatments commonly prescribed during
the acute phase of manic or mixed affective symptoms
occurring in a first-episode psychosis. Possible responses
presented were: quetiapine, risperidone, olanzapine,
‘other atypical’ (to be specified); ‘typical’ antipsychotic,
lithium, ‘the mood stabiliser’ (e.g. valproate or
carbamazepine) and ‘other treatment’ (to be specified).
Adult psychiatrists were more likely to consider olanza-
pine (39/47 v. 6/17; 2= 13.6, P50.001) and quetiapine
(6/47 v. 0/17 w2= 7.7, P= 0.005) compared with the
CAMHS group. Conversely, more of the CAMHS group
reported commonly using risperidone in this context,
compared with the AMHS group (14/17 v.10/47, w2= 19.9,
P50.001). Only a minority of both groups listed lithium or
‘typical antipsychotics’ as a commonly used treatment for
mood elevation in acute psychosis (lithium: AMHS 9/47;
CAMHS: 1/17; typical antipsychotics: AMHS 3/47;
CAMHS 1/17). Around a third of both groups reported
using benzodiazepines in this context.
Psychosocial interventions
Both groups were very similar in their view of psycho-
social interventions. Around half of the psychiatrists
reported using CBT and almost all family work/therapy or
supportive psychotherapy. Only one respondent in each
group reported using psychodynamic psychotherapy with
first-episode psychosis whereas 17 adult and three child
psychiatrists reported practising interpersonal
psychotherapy with patients affected by first-episode
psychosis. Almost all those who used these interventions
reported they were effective either ‘sometimes’ or ‘often’.
Discussion
This is the first study to explore potential difference in
attitudes and practices between CAMHS and AMHS
psychiatrists in relation to first-episode psychosis. A wide
variety of attitudes were reported by the psychiatrists
responding to this survey. Some differences may reflect
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Table 2. Respondents reports of their antipsychotic prescribing preferences (by proportion) for a ‘non-affective’ first episode of psychosisa
Prescribing preferences
Risperi-
done
Quetia-
pine
Aripipra-
zole
Olanza-
pine
Amisul-
pride Other Missing
Most commonly used first-line choice for
treating ‘non-affective’ FEP?b
AMHS, n= 42 9 7 7 19 0 0 5
CAMHS, n= 17 16 0 0 1 0 0 0
Second most commonly used first-line choice
for treating ‘non-affective’ FEP?c
AMHS, n= 44 19 8 7 9 1 0 3
CAMHS, n= 17 1 11 1 4 0 0 0
Most commonly used second-line choice for
treating ‘non-affective’ FEP?
AMHS, n= 41 11 9 10 10 4 0 6
CAMHS, n= 15 1 6 2 5 1 0 2
Second most commonly used second-line
choice for treating ‘non-affective’ FEP?d
AMHS, n= 41 10 8 13 5 4 1 6
CAMHS, n= 13 1 2 7 2 1 0 4
FEP, first-episode psychosis; Adult Mental Health Services (AMHS); Child and Adolescent Mental Health Services (CAMHS).
a.Where the inter-group difference is statistically significant at the P50.05 level the chi-squared and associated P values are given.
b. Risperodone: w2= 22.3, P50.001for inter-group difference and Olanzapine: w2= 6.9, P = 0.008 for inter-group difference.
c. Risperodone: w2= 6.9, P= 0.008 for inter-group difference and Quetiapine: w2= 13.6, P50.001for inter-group difference.
d. One respondent indicated that haloperidol was there secondmost commonly selected second-line agent.
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reality; for example, outcome in earlier onset psychosis
may be poorer compared with adult-onset illness.
However, some commonly reported views did not appear
to be based on scientific knowledge: for example, most
felt that ‘drug induced psychosis’ was a valid diagnosis
despite a lack of empirical evidence to support the utility
of this construct.8 It is also worth noting that the prog-
nostic factors given most weight by participants were
those related to service user’s behaviour (‘substance
misuse’ and ‘concordance’). However, remarkably few
inter-group differences in the views relating to first-
episode psychosis between adult and child psychiatrists
were elicited, despite working in markedly different sub-
specialities. Nevertheless, some notable trends in
prescribing practice were reported. Adult psychiatrists
were more likely to report using antidepressants for
medium-term depressive symptoms in contrast to
CAMHS prescribers, who were unlikely to prescribe an
antidepressant unless the depression was more chronic.
This is generally consistent with the NICE guidelines for
the treatment of depression in children and adolescents,
which stresses the cautious use of selective serotonin
reuptake inhibitors only after psychosocial interventions
have been ineffective.9 More surprising was the CAMHS
group’s reported reluctance to use quetiapine in favour of
risperidone for manic type symptoms, given that the NICE
bipolar guidelines for under 18s state ‘‘. . . when consid-
ering an antipsychotic, the risk of increased prolactin
levels with risperidone . . . should be considered . . .’’.6
These findings suggest that CAMHS psychiatrists are
more familiar with the NICE guidance on depression
compared with bipolar disorder. This would be unsur-
prising given the client mix of most child and adolescent
psychiatrists.
A second possibility that may explain the reported
affinity CAMHS psychiatrist have for prescribing risperi-
done for first-episode psychosis would be that this
medication is frequently prescribed for externalising
problems in youth, such as conduct disorder and will be
relatively familiar to psychiatrist working in CAMHS from
this context.10 Quetiapine is less likely than risperidone to
cause hyperprolactinaemia11 and extrapyramidal side-
effects12 and its more extensive use could potentially
reduce the exposure of children and adolescents with
first-episode psychosis to unnecessary adverse drug
reactions.
The high proportion of psychiatrists reporting the
practice of psychosocial interventions, such as CBT is
encouraging, with a trend to favour those with an
evidence base in psychosis treatment. Further studies
would be required to evaluate to what extent this is
borne out in reality.
The principal limitation of this study was the rela-
tively small number of participants, who all worked in the
same organisation. However, the response rate, at
around two-thirds of the target population, was relatively
high for a postal survey, although response bias cannot
be excluded. Although it is possible that some trends
were undetected due to type II error there was sufficient
power to demonstrate a number of differences in self-
reported practice. Moreover, many of the findings were
remarkably similar in both groups surveyed and this
makes the presence of undetected differences unlikely.
Further surveys would be required to assess the gener-
alisability of the trends detected in this study.
Conclusion
More work is required to understand what factors
underlie the marked variations in attitudes and practice of
professionals when dealing with young people affected
by psychotic symptoms. More national guidance, specific
to young people, would be helpful in harmonising
prescribing practice. However, care must also be taken in
disseminating and implementing such advice if it is to
impact on the care of service users and reduce treatment
inequalities across the age divide.
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